LIVN
LivaNova PLC
NASDAQ: LIVN · HEALTHCARE · MEDICAL DEVICES
$80.66
+0.35% today
Updated 2026-10-28
Market cap
$4.31B
P/E ratio
23.22
P/S ratio
2.94x
EPS (TTM)
$3.38
Dividend yield
—
52W range
$49 – $86
Volume
0.6M
LivaNova PLC (LIVN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$80.66
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$71.58
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.0B | $1.0B | $1.2B | $1.3B | $1.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 23.22x (capped 25x) · Margin: 12.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.